Style | Citing Format |
---|---|
MLA | Vp Ashok Velayudhan PILLAI, et al.. "Evaluation of 3D-Printed Polylactic Acid As a Bone Substitute: An Animal Study in a Rat Model." Clinical and Experimental Dental Research, vol. 11, no. 4, 2025, pp. -. |
APA | Vp Ashok Velayudhan PILLAI, Kg Mohanraj Karthik GANESH, S Maiti SUBHABRATA, Dn Veeraiyan Deepak NALLASWAMY, Ag Heboyan Artak G (2025). Evaluation of 3D-Printed Polylactic Acid As a Bone Substitute: An Animal Study in a Rat Model. Clinical and Experimental Dental Research, 11(4), -. |
Chicago | Vp Ashok Velayudhan PILLAI, Kg Mohanraj Karthik GANESH, S Maiti SUBHABRATA, Dn Veeraiyan Deepak NALLASWAMY, Ag Heboyan Artak G. "Evaluation of 3D-Printed Polylactic Acid As a Bone Substitute: An Animal Study in a Rat Model." Clinical and Experimental Dental Research 11, no. 4 (2025): -. |
Harvard | Vp Ashok Velayudhan PILLAI et al. (2025) 'Evaluation of 3D-Printed Polylactic Acid As a Bone Substitute: An Animal Study in a Rat Model', Clinical and Experimental Dental Research, 11(4), pp. -. |
Vancouver | Vp Ashok Velayudhan PILLAI, Kg Mohanraj Karthik GANESH, S Maiti SUBHABRATA, Dn Veeraiyan Deepak NALLASWAMY, Ag Heboyan Artak G. Evaluation of 3D-Printed Polylactic Acid As a Bone Substitute: An Animal Study in a Rat Model. Clinical and Experimental Dental Research. 2025;11(4):-. |
BibTex | @article{ author = {Vp Ashok Velayudhan PILLAI and Kg Mohanraj Karthik GANESH and S Maiti SUBHABRATA and Dn Veeraiyan Deepak NALLASWAMY and Ag Heboyan Artak G}, title = {Evaluation of 3D-Printed Polylactic Acid As a Bone Substitute: An Animal Study in a Rat Model}, journal = {Clinical and Experimental Dental Research}, volume = {11}, number = {4}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Vp Ashok Velayudhan PILLAI AU - Kg Mohanraj Karthik GANESH AU - S Maiti SUBHABRATA AU - Dn Veeraiyan Deepak NALLASWAMY AU - Ag Heboyan Artak G TI - Evaluation of 3D-Printed Polylactic Acid As a Bone Substitute: An Animal Study in a Rat Model JO - Clinical and Experimental Dental Research VL - 11 IS - 4 SP - EP - PY - 2025 ER - |